These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 27108359)

  • 1. Comparison of diffusion-weighted imaging and T2-weighted single shot fast spin-echo: Implications for LI-RADS characterization of hepatocellular carcinoma.
    Hicks RM; Yee J; Ohliger MA; Weinstein S; Kao J; Ikram NS; Hope TA
    Magn Reson Imaging; 2016 Sep; 34(7):915-21. PubMed ID: 27108359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
    Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
    World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of diffusion-weighted imaging in improving the sensitivity of LI-RADS classification of small hepatic observations suspected of malignancy.
    Basha MAA; Refaat R; Mohammad FF; Khamis MEM; El-Maghraby AM; El Sammak AA; Al-Molla RM; Mohamed HAE; Alnaggar AA; Hassan HA; Azmy TM; Alaa Eldin AM; Assy MM; AlAzzazy MZ; Altaher KM; Tantawy HF; Saber S; Amin MI; Alsowey AM; Radwan MHS; Taha HF; Fathy T; Hanafy AS; Abdelbary EH
    Abdom Radiol (NY); 2019 May; 44(5):1773-1784. PubMed ID: 30603882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low b-value (50-100) diffusion-weighted images detect significantly more hyperintense liver lesions in children than T2-weighted images.
    Grasparil ADI; Gupta H; Sheybani E; Chavhan GB
    Pediatr Radiol; 2019 Sep; 49(10):1299-1305. PubMed ID: 31292681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted imaging of the liver in patients with chronic liver disease: comparison of monopolar and bipolar diffusion gradients for image quality and lesion detection.
    Lewis S; Kamath A; Chatterji M; Patel A; Shyknevsky I; Dyvorne HA; Kuehn B; Taouli B
    AJR Am J Roentgenol; 2015 Jan; 204(1):59-68. PubMed ID: 25539238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric quantitative histogram analysis using diffusion-weighted magnetic resonance imaging to differentiate HCC from other primary liver cancers.
    Lewis S; Peti S; Hectors SJ; King M; Rosen A; Kamath A; Putra J; Thung S; Taouli B
    Abdom Radiol (NY); 2019 Mar; 44(3):912-922. PubMed ID: 30712136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Training in LI-RADS Version 2018 Improve Readers' Agreement with the Expert Consensus and Inter-reader Agreement in MRI Interpretation?
    Zhang N; Xu H; Ren AH; Zhang Q; Yang DW; Ba T; Wang ZC; Yang ZH
    J Magn Reson Imaging; 2021 Dec; 54(6):1922-1934. PubMed ID: 33963801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T.
    Wang H; Wang XY; Jiang XX; Ye ZX
    Acad Radiol; 2010 Feb; 17(2):239-43. PubMed ID: 19962912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma.
    Lee JY; Huo EJ; Weinstein S; Santos C; Monto A; Corvera CU; Yee J; Hope TA
    Abdom Radiol (NY); 2018 Jul; 43(7):1627-1633. PubMed ID: 29018942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.
    Ren AH; Zhao PF; Yang DW; Du JB; Wang ZC; Yang ZH
    J Magn Reson Imaging; 2019 Sep; 50(3):746-755. PubMed ID: 30648327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative detection of malignant liver tumors: Comparison of 3D-T2-weighted sequences with T2-weighted turbo spin-echo and single shot T2 at 1.5 T.
    Barat M; Soyer P; Dautry R; Pocard M; Lo-Dico R; Najah H; Eveno C; Cassinotto C; Dohan A
    Eur J Radiol; 2018 Mar; 100():7-13. PubMed ID: 29496082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-aided diagnosis program for classifying the risk of hepatocellular carcinoma on MR images following liver imaging reporting and data system (LI-RADS).
    Kim Y; Furlan A; Borhani AA; Bae KT
    J Magn Reson Imaging; 2018 Mar; 47(3):710-722. PubMed ID: 28556283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of Liver Imaging Reporting and Data System 2017 (LI-RADS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma.
    Kierans AS; Makkar J; Guniganti P; Cornman-Homonoff J; Lee MJ; Pittman M; Askin G; Hecht EM
    J Magn Reson Imaging; 2019 Jun; 49(7):e205-e215. PubMed ID: 30257054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying LI-RADS on Gadoxetate Disodium-Enhanced MRI: A Secondary Analysis of a Prospective Observational Study.
    Jiang H; Song B; Qin Y; Konanur M; Wu Y; McInnes MDF; Lafata KJ; Bashir MR
    J Magn Reson Imaging; 2022 Aug; 56(2):399-412. PubMed ID: 34994029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS.
    Cha DI; Choi GS; Kim YK; Kim JM; Kang TW; Song KD; Ahn SH
    Eur Radiol; 2020 Jul; 30(7):3723-3734. PubMed ID: 32128620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade.
    Nasu K; Kuroki Y; Tsukamoto T; Nakajima H; Mori K; Minami M
    AJR Am J Roentgenol; 2009 Aug; 193(2):438-44. PubMed ID: 19620441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.
    Nam SJ; Yu JS; Cho ES; Kim JH; Chung JJ
    Clin Radiol; 2017 Mar; 72(3):247-254. PubMed ID: 27789027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions.
    Ichikawa T; Haradome H; Hachiya J; Nitatori T; Araki T
    AJR Am J Roentgenol; 1998 Feb; 170(2):397-402. PubMed ID: 9456953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.